EVAR中肾上固定与肾下固定对肾功能并发症的影响
基于VSGNE 2003-2014年数据,比较肾上固定与肾下固定主动脉覆膜支架行EVAR的肾功能结局。常规使用者中肾上固定亦与肾功能障碍率升高相关。
要点
- 肾上固定与肾下固定EVAR患者基线合并症及eGFR无差异。
- 常规使用者中肾上固定组肾功能障碍率更高(3.7% vs 1.3%)。
核心结论
- 全部使用者和常规使用者中,肾上固定覆膜支架均与更高的肾功能恶化和住院时间延长相关。
研究设计与样本
- 回顾性队列研究,纳入VSGNE 2003-2014年2574例EVAR患者(肾上固定1264例,肾下固定1310例),其中888例由常规使用者置入(肾上固定409例,肾下固定479例)。
主要发现
- 校正后肾上固定与肾恶化风险增加相关(OR 2.0;95% CI 1.2-3.4),与住院延长相关(OR 1.8;95% CI 1.4-2.2)。
- 常规使用者中,肾上固定组肾功能障碍率3.7% vs 1.3%(p=.02;OR 2.9;95% CI 1.1-7.8)。
- 全部使用者中肾上固定组造影剂用量更多(102 mL vs 100 mL,p=.01),常规使用者中亦更多(110 mL vs 88 mL,p<.01)。
- 30天或1年死亡率无差异。
临床怎么用
- 选择EVAR覆膜支架固定方式时,需权衡肾上固定相关的肾功能恶化及住院时间延长风险。
局限性
- 需要更长期数据以确定肾功能下降的持续时间和严重程度,并明确减少移位或内漏的潜在获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies comparing endografts with suprarenal and infrarenal fixation for endovascular abdominal aortic aneurysm repair (EVAR) have found conflicting results and did not account for differences in patient selection. This study aims to evaluate the differences in outcomes among surgeons who routinely use either suprarenal or infrarenal fixation, as well as all surgeons in the Vascular Study Group of New England (VSGNE). METHODS: All patients undergoing EVAR in the VSGNE from 2003 to 2014 were identified. All ruptured aneurysms, repairs with concomitant procedures, and infrequently used stent grafts (<50) were excluded. Suprarenal endografts included Talent, Zenith, and Endurant; infrarenal endografts included AneuRx and Excluder. Grafts were compared among surgeons who used only one type of endograft (suprarenal or infrarenal) for >80% of cases, as well as all surgeons. Multivariate regression and Cox hazard models were utilised to account for patient demographics, comorbidities, operative differences, and procedure year. RESULTS: This study identified 2574 patients (suprarenal, 1264; infrarenal, 1310) with 888 endografts placed by routine users (suprarenal, 409; infrarenal, 479). There were no differences in baseline comorbidities, including the estimated glomerular filtration rate, between suprarenal and infrarenal fixation, or between patients with endografts placed by routine and non-routine users. Patients treated with suprarenal endografts received more contrast than all users (102 mL vs. 100 mL, p = .01) and routine users (110 mL vs. 88 mL, p < .01), but other vascular and operative details were similar. Among all users, patients treated with suprarenal grafts had higher rates of creatinine increase >.5 mg/dL (3.7% vs. 2.0%, p = .01), length of stay >2 days (27% vs. 19%, p < .01), and discharge to a skilled nursing facility (9.2% vs. 6.7%, p = .02). There were no differences in 30 day or 1 year mortality. Following adjustment, suprarenal stent grafts remained associated with an increased risk of renal deterioration (OR 2.0; 95% CI 1.2-3.4) and prolonged length of stay (OR 1.8; 95% CI 1.4-2.2). Among routine users, suprarenal fixation was also associated with higher rates of renal dysfunction (3.7% vs. 1.3%, p = .02; OR 2.9; 95% CI 1.1-7.8). CONCLUSION: Despite potential differences in patient selection, endografts with suprarenal fixation among all users and routine users were associated with higher rates of renal deterioration and longer length of hospital stay. Longer-term data are needed to determine the duration and severity of renal function decline and to identify potential benefits of decreased migration or endoleak.
引用
- Zettervall SL, Deery SE, Soden PA, et al. Editor's Choice - Renal complications after EVAR with suprarenal versus infrarenal fixation among all users and routine users. Eur J Vasc Endovasc Surg. 2017. PMID: 28779856. doi:10.1016/j.ejvs.2017.05.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。